compounded glp 1 safety Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines Patients seeking cheaper weight-loss drugs
Description
Treatment Treatment is symptomatic and supportive, there is no antidote
It belongs to the class of long-acting basal insulins
These medications are administered once or twice daily and have more pronounced effects on postprandial glucose due to their greater impact on gastric emptying
You should check your blood sugar before you start taking Saxenda and while you take Saxenda increased heart rate
For patients with type 2 diabetes and ASCVD, starting a GLP-1 RA carries a Class 1, Level of Evidence A recommendation in the most recent ESC and ACC guidelines
